COVID-19 and the cancer diagnosis crisis: an interview with Karol Sikora

Written by Karol Sikora (Rutherford Health plc, Hereford, UK)

oncology, COVID-19, cancer

Please introduce yourself, your research background and current research interests. I’m Professor Karol Sikora and I was Clinical Director for Cancer Services at Hammersmith, Charing Cross and St Mary’s Hospitals (London, UK) for nearly 20 years. I founded Rutherford Health PLC (UK) with Mike Moran 6 years ago to bring new investment into cancer care, including proton beam therapy. My research interests have been predictive testing using biomarkers to drive personalized medicine strategies. In my opinion, this is clearly the future of cancer care assisted by artificial intelligence analyzing big data and constructing algorithms for optimal care in individuals. How have you seen the...

To view this content, please register now for access

It's completely free